Practical implementation of COVID-19 patient flags into an antimicrobial stewardship program's prospective review.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Effectiveness and safety of a prospective audit and feedback-based antimicrobial stewardship program in hospitalized COVID-19 patients: a quasi-experimental before-and-after study.Frontiers in pharmacology · 2026
   Article
2. Leveraging antimicrobial stewardship programs in response to the coronavirus disease 2019 (COVID-19) public health emergency.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2022
   Review
3. It is complicated: Potential short- and long-term impact of coronavirus disease 2019 (COVID-19) on antimicrobial resistance-An expert review.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2022
   Review
4. A retrospective antibiotic prescribing assessment and examination of potential antibiotic stewardship targets in patients with COVID-19.JAC-antimicrobial resistance · 2021
   Article
5. Rapid adaptation of a local healthcare digital system to COVID-19: The experience in Birmingham (UK).Health policy and technology · 2021
   Article
6. Assessing the Impact of COVID-19 on Antimicrobial Stewardship Activities/Programs in the United Kingdom.Antibiotics (Basel, Switzerland) · 2021
   Article
7. Recent Updates in Antimicrobial Stewardship in Outpatient Parenteral Antimicrobial Therapy.Current infectious disease reports · 2021
   Article
8. A Crucial Role for Antimicrobial Stewardship in the Midst of COVID-19.Journal of microbiology & biology education · 2021
   Article
9. Leveraging Existing Strategies of Medication Stewardship to Preserve and Appropriately Use Critical Supplies.Mayo Clinic proceedings · 2020
   Article
10. Antimicrobial Stewardship at the Core of COVID-19 Response Efforts: Implications for Sustaining and Building Programs.Current infectious disease reports · 2020
    Review

Corrections and comments

• Comment on
  Review of: "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949.2020
• Comment on
  Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as